An Open-Label, Fixed-Sequence Study to Assess Effects of Clarithromycin on the Single-Dose Pharmacokinetics of JNJ-54861911 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 22 Oct 2014
At a glance
- Drugs JNJ 54861911 (Primary) ; Clarithromycin; Itraconazole
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 14 Oct 2014 Status changed from recruiting to completed, according to the ClinicalTrials.gov record.
- 12 Aug 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 25 Jul 2014 New trial record